Rodgers Mark C
SEC CIK 2092210 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NEM | Newmont | MD, Africa-Asia Pacific | 32.7K | — | $1.65M | 7 | 2026-02-23 | 2026-07-27 |
Most active insiders at NEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Toth Peter | EVP, Chief Sustain, Dev Off | — | $2.24M |
| 2 | Fry David James | Group Head Projects, Studies | — | $2.05M |
| 3 | Viljoen Natascha | Pres, COO | — | $1.69M |
| 4 | Rodgers Mark C | MD, Africa-Asia Pacific | — | $1.65M |
| 5 | Wexler Peter | EVP, CLO, Interim CFO | — | $1.47M |
| 6 | Thornton David John | MD, Americas | — | $1.35M |
| 7 | Tabolt Brian | SVP, CAO | — | $1.20M |
| 8 | Brook Bruce R | Dir | — | $537.3K |
| 9 | Palmer Thomas Ronald | CEO, Dir | — | $406.7K |
| 10 | Beaven Peter David | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-29 16:45 | 2026-07-27 | NEM | Newmont | Rodgers Mark C | COO | A - Grant | $0.00 | +6,954 | 32.7K | +27% | $0 | |
| 2026-03-04 | 2026-03-03 | NEM | Newmont | Rodgers Mark C | MD, Africa-Asia Pacific | S - Sale | $120.78 | -1,361 | 25.8K | -5% | -$164.4K | |
| 2026-03-03 | 2026-03-02 | NEM | Newmont | Rodgers Mark C | MD, Africa-Asia Pacific | S - Sale | $131.14 | -2,051 | 27.1K | -7% | -$269.0K | |
| 2026-03-03 | 2026-02-27 | NEM | Newmont | Rodgers Mark C | MD, Africa-Asia Pacific | A - Grant | $0.00 | +1,361 | 29.2K | +5% | $0 | |
| 2026-03-02 | 2026-02-27 | NEM | Newmont | Rodgers Mark C | MD, Africa-Asia Pacific | S - Sale | $130.00 | -4,443 | 27.8K | -14% | -$577.6K | |
| 2026-02-27 | 2026-02-25 | NEM | Newmont | Rodgers Mark C | MD, Africa-Asia Pacific | S - Sale | $125.00 | -5,147 | 32.2K | -14% | -$643.4K | |
| 2026-02-25 | 2026-02-23 | NEM | Newmont | Rodgers Mark C | MD, Africa-Asia Pacific | A - Grant | $0.00 | +4,426 | 37.4K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations